ACINO AG Patent applications |
Patent application number | Title | Published |
20140364294 | LATTICE LOSS REDUCTION - Methods for producing systems for the transdermal or permucosal administration of active substances and particularly transdermal therapeutic systems (TTS), wherein the active substance depots thereof have a shape that deviates from a rectangular design. | 12-11-2014 |
20140323996 | Transdermal Therapeutic System for Administering an Active Substance - The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, said system being suitable for an application period of at least three days, comprising the layers arranged in the following order with respect to each other:
| 10-30-2014 |
20140155845 | APPLICATION AID - The invention relates to a transdermal therapeutic system ( | 06-05-2014 |
20130261571 | Transdermal Therapeutic System For Administering Rivastigmine Or Derivatives Thereof - The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, comprising:
| 10-03-2013 |
20130110077 | Implant Cannula Having an Implant and a Method for Securing Implants in an Injection Cannula | 05-02-2013 |
20130096486 | Activatable Drug Dispensing System - The invention relates to a system ( | 04-18-2013 |
20130035631 | Cannula Device and Method and Device for Providing a Cannula Device with an Implant - To provide a cannula device ( | 02-07-2013 |
20120209223 | TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTRATION OF FENTANYL OR AN ANALOG THEREOF - Disclosed is a transdermal therapeutic system for administering an active ingredient through the skin comprising:
| 08-16-2012 |
20110111013 | TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTRATION OF FENTANYL OR AN ANALOGUE THEREOF - What is disclosed is a transdermal therapeutic system for administration of an active ingredient through the skin, comprising: (a) a back layer, (b) a reservoir present on the back layer, comprising the active ingredient, polyisobutylene, a gel former and a plasticizer, a portion of the active ingredient in the reservoir being present in the form of undissolved particles and the content of gel formers in the reservoir being at most 4% by weight (based in the total weight of the reservoir), the active ingredient being Fentanyl or an analogue thereof. | 05-12-2011 |
20100189793 | ELECTROPHORETIC TRANSDERMAL DELIVERY SYSTEM - A transdermal delivery system (TDS) for administering at least one active agent through the skin. The system has a first electrode, a second electrode, and a matrix located between the first and second electrodes. The TDS contains at least one active agent which is either alkaline or acidic. The system is configured such that when applying a voltage to the electrodes, the pH of the matrix, in the case of an alkaline active agent, does not exceed the pH of the active agent and, in case of an acidic active agent, does not fall below the pH of the active agent. | 07-29-2010 |
20100172959 | RESERVOIR SYSTEM WITH CLOSED MEMBRANE - A dermal or transdermal therapeutic system comprising a reservoir that contains at least one active substance, an active substance-permeable membrane which delimits the active-substance reservoir, and a closing layer. The closing layer is impermeable to the active substance at a temperature lying below the skin temperature while being permeable at skin temperature and above. | 07-08-2010 |